# Upfront Premedication For Reduction of Microvascular Obstruction and No-reflow in Treating ST-segment Elevation Myocardial Infarction

> **NCT05393557** · NA · NOT_YET_RECRUITING · sponsor: **Cairo University** · enrollment: 626 (estimated)

## Conditions studied

- STEMI
- Large Thrombus Burden
- No-Reflow Phenomenon

## Interventions

- **OTHER:** Upfront preparation of microcirculation to minimize risks of no-reflow and reperfusion injury

## Key facts

- **NCT ID:** NCT05393557
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-01-01
- **Primary completion:** 2026-05-31
- **Final completion:** 2026-11-30
- **Target enrollment:** 626 (ESTIMATED)
- **Last updated:** 2023-08-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05393557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05393557, "Upfront Premedication For Reduction of Microvascular Obstruction and No-reflow in Treating ST-segment Elevation Myocardial Infarction". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05393557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*